Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life population

被引:26
作者
Van de Wyngaert, Zoe [1 ,2 ]
Carpentier, Benjamin [3 ]
Pascal, Laurent [3 ]
Lionne-Huyghe, Pauline [4 ]
Leduc, Isabelle [5 ]
Srour, Micha [6 ]
Vasseur, Michele [7 ]
Demarquette, Helene [6 ]
Terriou, Louis [1 ]
Herbaux, Charles [1 ]
Manier, Salomon [1 ]
Bossard, Jean-Baptiste [1 ]
Barbieux, Sarah [1 ]
Chauvet, Paul [1 ]
Willaume, Alexandre [1 ]
Nudel, Morgane [1 ]
Bories, Claire [1 ,8 ]
Gibier, Jean-Baptiste [9 ]
Facon, Thierry [1 ]
Boyle, Eileen M. [1 ,10 ]
机构
[1] CHU Lille, Serv Malad Sang, Lille, France
[2] Sorbonne Univ, Hop St Antoine, AP HP, Hematol & Therapie Cellulaire,INSERM,UMRs 938, Paris, France
[3] Hop St Vincent, Serv Hematol, GHICL, Lille, France
[4] CH Arras, Serv Hematol, Arras, France
[5] CH Abbeville, Serv Med Interne, Abbeville, France
[6] CH Dunkerque, Serv Hematol, Dunkerque, France
[7] CHU Lille, Inst Pharm, Lille, France
[8] CH Lens, Serv Hematol, Lens, France
[9] CHU Lille, Ctr Biol Pathol, Serv Anatomopathol, Lille, France
[10] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA
关键词
AL-Amyloidosis; daratumumab; frailty; SURVIVAL; MYELOMA; MONOTHERAPY; MANAGEMENT;
D O I
10.1111/bjh.16282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E24 / E27
页数:4
相关论文
共 14 条
[1]   The application of the principles of geriatrics to the management of the older person with cancer [J].
Balducci, L ;
Beghe, C .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 35 (03) :147-154
[2]   Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial [J].
Boyle, Eileen M. ;
Leleu, Xavier ;
Petillon, Marie-Odile ;
Karlin, Lionel ;
Doyen, Chantal ;
Demarquette, Helene ;
Royer, Bruno ;
Macro, Margaret ;
Moreau, Philippe ;
Fostier, Karel ;
Marie-Lorraine, Chretien ;
Zarnitsky, Charles ;
Perrot, Aurore ;
Herbaux, Charles ;
Poulain, Stephanie ;
Manier, Salomon ;
Beauvais, David ;
Walker, Brian A. ;
Wardell, Christopher P. ;
Vincent, Laure ;
Frenzel, Laurent ;
Caillon, Helene ;
Susanna, Schraen ;
Dejoie, Thomas ;
Avet-Loiseau, Herve ;
Mohty, Mohamad ;
Facon, Thierry ;
Arnulf, Bertrand ;
Dib, Mamoun ;
Brechignac-Bureau, Sabine ;
Godmer, Pascal ;
Tempescul, Adrian ;
Fohrer, Cecile ;
Benboubker, Lotfi ;
Voillat, Laurent ;
Malfuson, Jean Valere ;
Mariette, Clara ;
Tiab, Mourad ;
Rigaudeau, Sophie ;
Jaccard, Arnaud ;
Stoppa, Anne-Marie ;
Eisenmann, Jean-Claude ;
Rodon, Philippe ;
Kolb, Brigitte ;
Decaux, Olivier ;
Onraed, Brigitte ;
Attal, Michel ;
Hulin, Cyrille .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (03) :319-327
[3]   How I treat elderly patients with plasma cell dyscrasias [J].
Gavriatopoulou, Maria ;
Fotiou, Despoina ;
Ntanasis-Stathopoulos, Ioannis ;
Kastritis, Efstathios ;
Terpos, Evangelos ;
Dimopoulos, Meletios Athanasios .
AGING-US, 2018, 10 (12) :4248-4268
[4]   European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias [J].
Gavriatopoulou, Maria ;
Musto, Pellegrino ;
Caers, Jo ;
Merlini, Giampaolo ;
Kastritis, Efstathios ;
van de Donk, Niels ;
Gay, Francesca ;
Hegenbart, Ute ;
Hajek, Roman ;
Zweegman, Sonja ;
Bruno, Benedetto ;
Straka, Christian ;
Dimopoulos, Meletios A. ;
Einsele, Hermann ;
Boccadoro, Mario ;
Sonneveld, Pieter ;
Engelhardt, Monika ;
Terpos, Evangelos .
LEUKEMIA, 2018, 32 (09) :1883-1898
[5]   Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis [J].
Kaufman, Gregory P. ;
Schrier, Stanley L. ;
Lafayette, Richard A. ;
Arai, Sally ;
Witteles, Ronald M. ;
Liedtke, Michaela .
BLOOD, 2017, 130 (07) :900-902
[6]   Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score [J].
Kumar, Shaji K. ;
Gertz, Morie A. ;
Lacy, Martha Q. ;
Dingli, David ;
Hayman, Suzanne R. ;
Buadi, Francis K. ;
Short-Detweiler, Kristen ;
Zeldenrust, Steven R. ;
Leung, Nelson ;
Greipp, Philip R. ;
Lust, John A. ;
Russell, Stephen J. ;
Kyle, Robert A. ;
Rajkumar, S. Vincent ;
Dispenzieri, Angela .
MAYO CLINIC PROCEEDINGS, 2011, 86 (01) :12-18
[7]   Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma [J].
Lokhorst, H. M. ;
Plesner, T. ;
Laubach, J. P. ;
Nahi, H. ;
Gimsing, P. ;
Hansson, M. ;
Minnema, M. C. ;
Lassen, U. ;
Krejcik, J. ;
Palumbo, A. ;
van de Donk, N. W. C. J. ;
Ahmadi, T. ;
Khan, I. ;
Uhlar, C. M. ;
Wang, J. ;
Sasser, A. K. ;
Losic, N. ;
Lisby, S. ;
Basse, L. ;
Brun, N. ;
Richardson, P. G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13) :1207-1219
[8]   Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial [J].
Lonial, Sagar ;
Weiss, Brendan M. ;
Usmani, Saad Z. ;
Singhal, Seema ;
Chari, Ajai ;
Bahlis, Nizar J. ;
Belch, Andrew ;
Krishnan, Amrita ;
Vescio, Robert A. ;
Victoria Mateos, Maria ;
Mazumder, Amitabha ;
Orlowski, Robert Z. ;
Sutherland, Heather J. ;
Blade, Joan ;
Scott, Emma C. ;
Oriol, Albert ;
Berdeja, Jesus ;
Gharibo, Mecide ;
Stevens, Don A. ;
LeBlanc, Richard ;
Sebag, Michael ;
Callander, Natalie ;
Jakubowiak, Andrzej ;
White, Darrell ;
de la Rubia, Javier ;
Richardson, Paul G. ;
Lisby, Steen ;
Feng, Huaibao ;
Uhlar, Clarissa M. ;
Khan, Imran ;
Ahmadi, Tahamtan ;
Voorhees, Peter M. .
LANCET, 2016, 387 (10027) :1551-1560
[9]   Dangerous small B-cell clones [J].
Merlini, Giampaolo ;
Stone, Marvin J. .
BLOOD, 2006, 108 (08) :2520-2530
[10]   New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes [J].
Palladini, Giovanni ;
Dispenzieri, Angela ;
Gertz, Morie A. ;
Kumar, Shaji ;
Wechalekar, Ashutosh ;
Hawkins, Philip N. ;
Schoenland, Stefan ;
Hegenbart, Ute ;
Comenzo, Raymond ;
Kastritis, Efstathios ;
Dimopoulos, Meletios A. ;
Jaccard, Arnaud ;
Klersy, Catherine ;
Merlini, Giampaolo .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (36) :4541-4549